Ecuador vs Grenada: Cause of death, by non-communicable diseases, ages 5-14
Ecuador
50.4%
in 2021
Grenada
49.2%
in 2021
Ecuador rank
53rd
Grenada rank
55th
Cause of death, by non-communicable diseases, ages 5-14 over time
- Ecuador
- Grenada
How they compare
Ecuador currently reports 50.4% against 49.2% in Grenada, a difference of 1.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Grenada ahead.
Ecuador ranks 53rd and Grenada ranks 55th of 185 countries.
Grenada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Ecuador | Grenada | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 36.0% | 58.1% | 22.1% | Grenada |
| 2010s | 46.9% | 71.8% | 24.9% | Grenada |
| 2020s | 51.1% | 59.6% | 8.5% | Grenada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 5-14, Ecuador or Grenada?
- Ecuador, at 50.4% against 49.2% in Grenada as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 5-14 between Ecuador and Grenada?
- 1.2%, with Ecuador ahead.
- How many years of comparable data are there for Ecuador and Grenada?
- 6 years are reported by both, from 2000 to 2021.
- How do Ecuador and Grenada rank globally for cause of death, by non-communicable diseases, ages 5-14?
- Ecuador ranks 53rd and Grenada ranks 55th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 5-14 (% of total deaths ages 5-14). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 5-14 due to non-communicable diseases divided by number of all deaths ages 5-14, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.